Is Bluebird Bio Inc (BLUE) a good stock to buy?

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "We are reluctant to say this, but we told you On February 27, we published an article entitled Recession is imminent: we need a travel ban NOW and predicted a US recession when the S&P 500 index was trading at 3150. We also told you to sell the market short and buy long-term government bonds. Our article also called for a total international travel ban. While we warned you, President Trump minimized the threat and didn’t respond immediately. As a result of his inaction, we will now experience a deeper recession (see why hell is coming). “Data-reactid =” 12 “> We hate to say that, but we told you so. On February 27th we published an article entitled Recession is imminent: we need a travel ban NOW and predicted a US recession when the S&P 500 index was trading at 3150. We also told you to sell the market short and buy long-term government bonds. Our article also called for a total international travel ban. While we warned you, President Trump minimized the threat and didn’t respond immediately. As a result of his inaction, we will now experience a deeper recession (see why hell is coming).

In these volatile markets, we’re reviewing hedge fund filings to find out which direction each stock could go. Before we spend countless hours researching a company, let’s first analyze what insiders, hedge funds and billionaire investors think of the stock. This is a necessary first step in our investment process as our research has shown that the consensus returns of the elite investors have been exceptional. The following sections tell you what Bluebird Bio Inc’s (NASDAQ: BLUE) billionaire investors and hedge funds think.

<p class = "Artboard-Atom Artboard-Text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "Is Bluebird Bio Inc (NASDAQ: BLUE) an excellent stock to buy now? The best stock pickers become more confident. The number of long hedge fund positions has recently increased by 16. Our calculations have also shown that BLUE is not among the 30 most popular stocks among hedge funds (click for the Q4 ranking and watch the video at the end of this article for the Q3 ranking). BLUE was in 33 hedge fund portfolios at the end of the fourth quarter of 2019. At the end of the previous quarter, there were 17 hedge funds in our database with BLUE positions. “data-reactid =” 14 “> Is Bluebird Bio Inc (NASDAQ: BLUE) an excellent stock to buy now? The best stock pickers become more confident. The number of long hedge fund positions has recently increased by 16. Our calculations also showed that BLUE is not one of the 30 most popular hedge fund stocks (click for the Q4 rankings and watch the video at the end of this article for the Q3 rankings). BLUE was in 33 hedge fund portfolios at the end of the fourth quarter of 2019. Our database contained 17 hedge funds with BLUE positions at the end of the previous quarter.

So why do we pay attention to the mood in hedge funds before we make investment decisions? Our research has shown that small-cap stocks in hedge funds have managed to hit the market in double digits annually between 1999 and 2016, but the margin of outperformance has decreased in recent years. Nevertheless, we were able to identify in advance a selected group of hedge fund holdings that have outperformed the S&P 500 ETFs by more than 41 percentage points since March 2017 (see details here). We also pre-identified a select group of hedge fund holdings that underperformed the market by 10 percentage points between 2006 and 2017. Interestingly, the underperformance margin of these stocks has increased in recent years. Investors who have been in the market for a long time and sell these stocks would have achieved an annual return of more than 27% between 2015 and 2017. Since February 2017, we have been tracking and sharing the list of these stocks in our quarterly newsletter. Even if you are not familiar with the short sale of stocks, you should at least avoid opening long positions in stocks that are in our short portfolio.

Arthur B. Cohen and Joseph Healey of Healthcor Management LP

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "We don't leave any stone unturned when we look for the Looking for Next A great investment idea, for example, we believe electric vehicles and energy storage will become huge markets and we want to take advantage of the falling lithium prices amid the COVID 19 pandemic, so we're exploring investment opportunities like this one. We read letters from hedge fund investors and hear stock prices at hedge fund conferences. Our best call in 2020 was the short sale of the market when the S&P 500 was trading around 3150 after realizing the importance of the coronavirus pandemic before most investors. With this in mind, let’s take a look at key hedge fund measures around Bluebird Bio Inc (NASDAQ: BLUE). “Data-reactid =” 33 “> We are doing everything we can to find the next great investment idea. For example: we believe that electric vehicles and energy storage will become huge markets and we want the falling lithium prices amid the COVID-19 pandemic That’s why we examine investment opportunities like this one. We read letters from hedge fund investors and hear stock prices at hedge fund conferences. Our best call in 2020 was the short sale of the market when the S&P 500 was trading around 3150 after realizing the importance of the coronavirus pandemic before most investors. With this in mind, let’s take a look at key hedge fund measures around Bluebird Bio Inc (NASDAQ: BLUE).

What did hedge funds do with Bluebird Bio Inc (NASDAQ: BLUE)?

At the beginning of the first quarter of 2020, a total of 33 of the hedge funds covered by Insider Monkey were optimistic about this share, a change of 94% compared to the previous quarter. For comparison: a year ago, 16 hedge funds held shares or bullish call options in BLUE. So let’s check which hedge funds were among the top holders of the stock and which hedge funds took big steps.

In particular, Casdin Capital was the largest shareholder of bluebird bio Inc (NASDAQ: BLUE). A share of $ 85.1 million was reported at the end of September. Casdin Capital was followed by Citadel Investment Group, which had amassed a $ 69.6 million stake. Healthcor Management LP, Armistice Capital and Adage Capital Management were also very impressed with the share and became one of the company’s largest hedge fund holders. With regard to the portfolio weights assigned to each position, Casdin Capital Bluebird Bio Inc (NASDAQ: BLUE) assigned the greatest weight with around 7.83% of its 13F portfolio. Logos Capital is also relatively optimistic about the stock, providing 4.42 percent of its 13F stock portfolio for BLUE.

As expected, major hedge funds led the bull herds. Armistice Capital, managed by Steven Boyd, established the largest position in Bluebird Bio Inc (NASDAQ: BLUE). Armistice Capital had invested $ 29.5 million in the company at the end of the quarter. Phill Gross and Robert Atchinson’s Adage Capital Management also opened a $ 25 million position in the quarter. The following funds were also among the new BLUE investors: Arsani Williams Logos Capital, John Overdeck and David Siegels Two Sigma Advisors and Peter Mullers PDT Partners.

Let’s also look at hedge fund activity in other stocks – not necessarily in the same industry as Bluebird Bio Inc (NASDAQ: BLUE), but valued similarly. We’ll take a look at Emcor Group Inc (NYSE: EME), Graphic Packaging Holding Company (NYSE: GPK), Black Hills Corporation (NYSE: BKH) and Carter’s, Inc. (NYSE: CRI). All market capitalizations of these stocks are similar to BLUE’s market capitalization.

[table] Ticker, number of HFs with positions, total value of the HF positions (x1000), change of the HF position EME, 29.238201.1 GPK, 39.550850.3 BKH, 24.200216.3 CRI, 21.263204, -4 average 28.25.313118, 0.75 [/table]

View the table here if formatting problems occur.

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "As you can see, these stocks had an average of 28 , 25 hedge funds with bullish positions and an average amount invested in these stocks were $ 313 million, compared to $ 369 million in BLUE and Graphic Packaging Holding Company (NYSE: GPK) is the most popular stock in On the other hand, Carter's, Inc. (NYSE: CRI) is the least popular stock with only 21 bullish hedge fund positions, and Bluebird bio Inc (NASDAQ: BLUE) is not the most popular stock in this group, but interest hedge funds are still a slightly positive signal above average, but we'd rather spend our time researching stocks that hedge funds are stacked on, and our calculations have shown that the 20 most popular hedge fund stocks will return 41 in 2019, 3% earned and the S&P 500 ETF (SPY) outperformed by 10.1 percentage points. These stocks lost 17.4% by March 25, 2020, but outperformed the market by 5.5 percentage points. Unfortunately, BLUE was nowhere near as popular as those 20 stocks and hedge funds that opted for BLUE, as the stock returned -46.1% over the same period and underperformed the market. If you want to invest in large-cap stocks with great upside potential, you should look at the 20 most popular stocks among hedge funds, as many of these stocks have already outperformed the market this year. Video: Click the image to watch our video about the 5 most popular hedge fund stocks.“data-reactid =” 61 “> As you can see, these stocks had an average of 28.25 bullish hedge funds and the average amount invested in these stocks was $ 313 million, which in the case of BLUE was $ 369 million. Graphic Packaging Holding Company (NYSE: GPK) is the most popular stock in this table. On the other hand, Carter’s, Inc. (NYSE: CRI) is the least popular with only 21 bullish hedge fund positions. Bluebird Bio Inc (NASDAQ: BLUE) is not the most popular stock in this group, but interest in hedge funds is still above average, which is a slightly positive signal, but we would rather spend our time looking for stocks on the hedge funds stack up, and our calculations show that the 20 most popular stocks among hedge funds are funds, which returned 41.3% in 2019 and outperformed the S&P 500 ETF (SPY) by 10.1 percentage points nude. These stocks lost 17.4% in 2020 through March 25, but outperformed the market by 5.5 percentage points. Unfortunately, BLUE was not nearly as popular as these 20 stocks and hedge funds, bets on BLUE were disappointed as the stock returned -46.1% over the same period and underperformed the market. If you want to invest in large-cap stocks with great upside potential, you should look at the 20 most popular stocks among hedge funds, as many of these stocks have already outperformed the market this year. Video: Click the image to watch our video about the 5 most popular hedge fund stocks.

5 most popular stocks among hedge funds5 most popular stocks among hedge funds

5 most popular stocks among hedge funds

Disclosure: none. This article was originally published by Insider Monkey.

<p class = "Artboard-Atom Artboard-Text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "Related content“data-reactid =” 75 “>Related content

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.